Related Experiment Video

Updated: Aug 29, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Methicillin resistant Staphylococcus aureus in the critically ill

K J Hardy1, P M Hawkey, F Gao

  • 1Health Protection Agency, West Midlands Public Health Laboratory, and Intensive Care Unit, Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, UK.

British Journal of Anaesthesia
|December 11, 2003
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing hospital threat. This review covers MRSA evolution, identification, risk factors in critically ill patients, and future antibiotic strategies to combat this infection.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant nosocomial pathogen globally.
  • Critically ill patients in intensive care units (ICUs) face heightened risks of MRSA acquisition.
  • Understanding MRSA epidemiology is crucial for effective infection control.

Purpose of the Study:

  • To review the evolution and current status of MRSA.
  • To discuss methods for MRSA identification and epidemiological typing.
  • To explore risk factors, clinical outcomes, and future therapeutic options for MRSA in critically ill patients.

Main Methods:

  • Literature review of current research on MRSA.
  • Analysis of epidemiological data and typing techniques.
  • Discussion of clinical risk factors, morbidity, and mortality.

Main Results:

  • MRSA continues to evolve, posing ongoing challenges in healthcare settings.
  • Various molecular techniques aid in MRSA identification and tracking.
  • Critically ill patients exhibit specific risk factors contributing to MRSA infections.

Conclusions:

  • Effective identification and typing are essential for controlling MRSA spread.
  • Addressing specific risk factors in ICUs can mitigate MRSA infections.
  • Future antibiotic development is critical for managing MRSA morbidity and mortality.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...